Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Nasdaq Announces Quarterly Dividend of $0.24 Per Share
-
Valley National Bancorp Announces Third Quarter 2024 Results
-
Virtu Announces Third Quarter 2024 Results
-
Migrant Rights Network: We Have a Consensus: Permanent Residency & Rights, Not Cuts
-
The Great Twine Round-Up Comes to Alberta with $12,000 in total Cash Prizes
-
Pool Corporation Reports Third Quarter Results
-
enCore Energy Continues to Expand Uranium Production at the Alta Mesa Plant
-
DTE Energy reports third quarter 2024 accomplishments, earnings and investments in improving energy infrastructure
-
EyePoint Pharmaceuticals Announces First Patient Dosed in Global Phase 3 LUGANO Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration
-
The Simply Good Foods Company Reports Fiscal Fourth Quarter and Full Fiscal Year 2024 Financial Results and Provides Full Fiscal Year 2025 Outlook
-
Ultralife Corporation to Report Third Quarter Results on November 8, 2024
-
OLD REPUBLIC REPORTS RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2024
-
CULT Food Science Subsidiary Further Foods Launches Noochies! Immune Sprinkles for Dogs and Cats
-
WELL Health to Announce Third Quarter 2024 Financial Results on November 7, 2024
-
Ardagh Group Third Quarter 2024 Results
-
Step into the Magic: MINISO Canada's New IP Collection Store Opens at Eaton Centre
-
Epitopea Closes USD $31 million Pre-Series A Financing
-
BranchOut Food Shareholder Update: Projects $15M Run Rate and Positive Cash Flow for Q1 2025 Amid Surge in New Orders as Peru Factory Opens
-
HYPE Innovation Named Leader in SPARK Matrix™: Innovation Management, Q3 2024
-
AAON Announces Third Quarter 2024 Conference Call And Webcast
-
New York’s RTS awards NFI subsidiary New Flyer order for 44 Xcelsior heavy-duty transit buses
-
Hyro Transforms Patient Care with AI-Powered Assistants and Cisco's Webex Contact Center
-
Harley-Davidson Delivers Third Quarter Financial Results
-
CompScience and Keystone Natural Foods Radically Improve Worker Safety
-
Alkermes plc Reports Third Quarter 2024 Financial Results
-
Ayana Bio to Showcase Plant Cell Advantage™ Health & Wellness Ingredients at SupplySide West 2024
-
Old Navy Unveils 'Love is in the House' in Holiday Campaign with Jennifer Hudson
-
Electric Era Powers Costco's Rapid EV Charging Rollout: 7-Week Deployment Sets New Industry Standard for Retailers
-
NayaOne to Accelerate Enterprise Adoption of Generative AI in Financial Services using NVIDIA AI
-
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2024 Financial Results
-
Catalyst Bancorp, Inc. Announces 2024 Third Quarter Results
-
Jade Biosciences Appoints Tom Frohlich as Chief Executive Officer and Hetal Kocinsky as Chief Medical Officer; Forms Board of Directors and Expands Financing to $95 Million
-
Ardagh Metal Packaging S.A. - Third Quarter 2024 Results
-
Swift Current Energy Brings Online 138 MW Harvest Gold Solar Project in Mississippi
-
Keeper Security Introduces New Updates to KeeperFill Browser Extension, Improving Security and Usability Across Devices
-
Keurig Dr Pepper Reports Q3 2024 Results and Reaffirms Fiscal 2024 Guidance
-
Volvo Study Reveals that rising fuel prices and environmental concerns are driving Gen Z to consider plug-in hybrids for their future vehicle choice
-
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024
-
Corero Network Security Launches New Scalable 400G DDoS Hardware Appliance with Exclusive Trade-In Program
-
Cancer Research UK and KisoJi Biotechnology Collaborate to Advance the First Naked Antibody Against TROP2 Into the Clinic
-
Accent Therapeutics Announces FDA Clearance of IND Application for ATX-559, a First-In-Class Oral DHX9 Inhibitor
-
Beasley Broadcast Group, Inc. Appoints Lauren Burrows Coleman as Chief Financial Officer
-
KCA Confirms Commitment to Xali Gold’s El Oro Tailings Project
-
WATT CAPITAL CEO NADINE WATT JOINS ADEPT ADVISORY BOARD
-
Kymera Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader, for the Treatment of TH2 Immuno-Inflammatory Diseases
-
Expro Group Holdings N.V. Announces Third Quarter 2024 Results
-
BPGbio to Present Novel E2-based Targeted Protein Degradation Program at TPD and Induced Proximity Summit
-
SK keyfoundry expands high-voltage foundry services portfolio with the launch of HVIC process technology
-
SOUTHWEST AIRLINES ANNOUNCES APPOINTMENT OF SIX NEW INDEPENDENT DIRECTORS
-
Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference
